gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Male or female patients aged 20 years and older at the time of informed consent 2)Patients who are able to take orally 3)Patients who will receive radical total gastrectomy for cancer irrespective of technique 4) Patients who will receive radical distal gastrectomy for cancer irrespective of technique 4)Patients who have not received pretreatment for gastric cancer (radiation, chemotherapy, and hormonal therapy etc.) 5)Patients who fully understand the study procedures and have given voluntary written informed consent after a full explanation is given
Exclusion criteria
Exclusion criteria: 1)Patients with ileus 2)Patients with no residual intestinal function 3)Patients with severe liver disorder AST (GOT) or ALT (GPT) ≥ 2.5 times the upper limit of normal at hospital 4)Patients with severe renal disorder Cr ≥ 2.0 mg/dL 5)Patients with abnormal glucose metabolism such as severe diabetes mellitus : HbA1c ≥ 7.0% 6)Patients with allergy to any ingredient of milk, wheat, soy bean, or salmon 7)Pregnant women, women suspected of being pregnant, or lactating women 8)Patients with active double cancer and/or multiple cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent change and amount of change in body weight (amount of change in BMI) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Percent change and amount of change in grip strength 2)QOL (EORTC QLQ-C30) 3)Percentage of completed chemotherapy (only patients receiving chemotherapy) 4)Nutritional indexes 5)Body composition 6)Occurrence of adverse events of ONS | — |
Countries
Japan,Asia(except Japan)
Contacts
THE UNIVERSITOY OF TOKYO Department of Gastrointestinal Surgery